Fig. 10. MIP (A, C) and axial non contrast fused 18F-FDG PET/CT (B) in 20-year-old man with ALK positive anaplastic large cell lymphoma. A. Patient had.

Slides:



Advertisements
Similar presentations
Fig. 2. Computed tomography (CT) and magnetic resonance images of 34-year-old man with right nasal tumor diagnosed as cavernous hemangioma. A. Early-phase.
Advertisements

Fig FDG PET-CT in patient with cutaneous T-cell lymphoma with treatment response. Baseline (A) and post treatment (B) axial fused PET-CT images demonstrate.
Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A
Fig. 2. Arterial fluorodeoxyglucose (FDG) uptake related to atherosclerosis. On positron emission tomography (PET) coronal (A), PET/CT fusion coronal (B),
Fig F-fluoride positron emission tomography (PET) in atherosclerosis
Fig. 3. Imaging factors alone in case 14 with cerebellar heterotopia. A. Axial proton density T2-weighted initial MR image (0.3T, non-epilepsy protocol)
Fig year-old man with CLL and transformation to DLBCL. A
Fig year-old woman with invasive lobular breast cancer. A
Fig. 5. Both imaging and lesion factors in case 3 with focal cortical dysplasia. A. Axial T2-weighted initial MR image (1.5T, non-epilepsy protocol) obtained.
Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group 
Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.
74-year-old man with stage T2a Gleason score prostate cancer (prostate specific antigen = ng/mL) in right transition zone (TZ) with history.
Shustov AR et al. Proc ASH 2010;Abstract 961.
Fig. 2. Contrast-enhanced head and neck MRA of two patients with left-arm injections. A. MIP image of a 78-year-old male shows optimal opacification with.
A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment.
Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell.
Fig. 2. A 36-year-old woman underwent right breast-conserving surgery due to invasive ductal cancer seven months prior. A mediolateral oblique mammography.
Fig. 1. Screening breast MR images of 31-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as negative finding.
Fig. 17. A 54-year-old male with recent voice change. A
Fig year-old man with lymph-node metastasis from pelvic extraskeletal Ewing sarcoma family of tumors. A. Axial contrast-enhanced computed tomography.
Fig. 2. Atypical response to VEGF-targeted therapy in colon cancer
Near Complete Response in a Patient with Classical Hodgkin Lymphoma Treated with Brentuximab Vedotin Concurrent with Radiation Therapy - DOI: /
Hugo J.A. Adams, Rutger A.J. Nievelstein, Thomas C. Kwee  Blood Reviews 
Fig. 5. A 13-year-old boy with epidermoid cyst of the skull
Fig FDG PET-CT and diagnostic contrast-enhanced chest CT in patient with angioimmunoblastic T-cell lymphoma. MIP image (A) demonstrates intense 18FDG.
Minimal Change Disease as Initial Presentation of ALK-Positive Anaplastic Large-Cell Lymphoma in a Pediatric Patient - DOI: / Fig. 1. Renal.
Fig year-old woman with dedifferentiated retroperitoneal liposarcoma
Fig. 2. Screening breast MR images of 46-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as multiple benign.
Fig year-old male with left shoulder weakness after radiation therapy for metastatic lymph nodes in left supraclavicular area due to right lung.
Fig. 3.Findings of the 39-year-old man with extrapulmonary mass-like lesions (case 3). (A, B) Abdominal CT on admission day shows multiple hepatic nodules.
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Harika Tirumani, MBBS, Michael H
Jaden D. Evans, MD, Krishan R
PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,
by Thomas S. Uldrick, and Richard F. Little
Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography  Walter.
Yuji Nakamoto  Clinical Lymphoma, Myeloma and Leukemia 
The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection.
Fig year-old male with multiple cerebral abnormalities. A
Foreign-body granuloma mimicking post-chemotherapy residual seminoma: A case of true-negative findings using diffusion-weighted whole-body magnetic resonance.
Volume 65, Issue 4, Pages (April 2014)
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.
11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer  I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,
Carmel G. Cronin, Michael Moore, Michael A. Blake 
PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies  Steven P. Rowe, Kenneth J.
Volume 71, Issue 6, Pages (June 2017)
Yuko Ogawa, Koichiro Abe, Akiko Sakoda, Hiromi Onizuka, Shuji Sakai 
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Hypermetabolism of Vertebral Arteries Revealing Giant Cell Arteritis  Aurélie Daumas, MD,
Metabolic response by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). a) FDG PET/CT for patient 2 at baseline.
European Urology Oncology
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.
A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib  Oliver Gautschi, MD, Chantal Pauli, MD, Klaus Strobel, MD, Astrid Hirschmann,
Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing  Michael Guandalini, MBBS (Hons), BPhty, Karin Steinke, MD, MS, PD,
Acute intramural hematoma of the aorta as a cause of positive fluorodeoxyglucose positron emission tomography/computed tomography  Alex Ryan, MD, Barry.
Axillary Mass and Hypercalcemia: The Value of a Physical Examination
Detection of an Asymptomatic Right-Ventricle Cardiac Metastasis from a Small-Cell Lung Cancer by F-18-FDG PET/CT  Maria Victoria Orcurto, MD, Angelika.
Beware of Underlying Malignancy: Acquired Ichthyosis
Fig year-old male with brain metastases from lung cancer
B. CT bone setting finding, which corresponds to the location of the…
CT (left of images) showing calcified areas and PET (right of images) scans showing increased FDG-PET metabolic activity in the mediastinal mass (A) and.
Fig. 1. Axial CT images in 78-year-old man with history of esophageal cancer.A. Contrast-enhanced chest CT image shows 1.3-cm solid nodule in right upper.
Fig. 5. Measurement of extramural depth of tumor invasion in T3 rectal cancer. A. MRI measurements on axial (left) and coronal (right) views are 6.1 and.
Fig. 2. Axial CT images in 21-year-old man diagnosed with acquired immunodeficiency syndrome.He was referred for incidentally detected pulmonary mass during.
Fig. 3. Representative false-positive cases. A
Fig year-old woman with newly diagnosed inflammatory breast cancer. A-C. Axial fused PET-CT images of supraclavicular region, upper and mid chest.
Fig. 1. Radiologic findings of Case 1
Fig year-old female patient with Wallerian degeneration due to intracerebral hematomas. A, B. Axial T2 (A) and T1-weighted (B) images show two.
Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT  Shuichi.
Presentation transcript:

Fig. 10. MIP (A, C) and axial non contrast fused 18F-FDG PET/CT (B) in 20-year-old man with ALK positive anaplastic large cell lymphoma. A. Patient had been diagnosed one year earlier and treated with brentuximab but had relapsed 6 months after completing treatment. New baseline PET/CT demonstrated residual lymphadenopathy in right external iliac and inguinal lymph nodes (arrows). B. Axial fused PET/CT demonstrates FDG avid right inguinal lymph node (arrow) with SUVmax 5.5. C. Patient was treated with salvage chemotherapy (gemcitabine, vinorelbine and doxil) with response to treatment and resolution of right pelvic lymphadenopathy on PET/CT performed 8 weeks later. ALK = anaplastic lymphoma kinase, MIP = maximum intensity projection, PET = positron emission tomography Fig. 10. MIP (A, C) and axial non contrast fused 18F-FDG PET/CT (B) in 20-year-old man with ALK positive anaplastic large cell lymphoma. A. Patient had been diagnosed one year earlier and treated with brentuximab but had relapsed 6 months after completing treatment. New baseline PET/CT demonstrated residual lymphadenopathy in right external iliac and inguinal lymph . . . Korean J Radiol. 2017 Jan-Feb;18(1):6-17. https://doi.org/10.3348/kjr.2017.18.1.6